Table: Wakamoto Pharm -2017/18 parent results

Wakamoto Pharmaceutical

15/05/2018 07:00

May 15 (Reuters)- 
          Wakamoto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2018    Mar 31, 2017    Mar 31, 2019      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales           10.90           10.83           11.10                  
               (+0.7 pct)      (-3.2 pct)      (+1.8 pct)                
  Operating    loss 73 mln       87 mln       loss 510 mln               
                               (+4.9 pct)                                
  Recurring    loss 80 mln       102 mln      loss 510 mln               
                               (-17.6 pct)                               
  Net            125 mln         94 mln       loss 380 mln               
               (+32.9 pct)    (+361.9 pct)                               
  EPS           3.63 yen        2.73 yen     loss 10.95 yen              
  Ann Div       3.00 yen        3.00 yen                                 
  -Q2 Div          NIL             NIL                                   
  -Q4 Div       3.00 yen        3.00 yen                                 
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T